Dr. Ke Xu earned his first degree in Microbiology in 1989 from School of Life Sciences in Nankai University (China), and his Ph.D. in Cell and Molecular Biology in 2001 from University of Essex (UK). He completed his postdoctoral training at the Institute of Cancer Research (UK), studying on the induction of leukemia cell apoptosis and differentiation. Dr. Ke Xu carried out his research fellowship at Imperial College London (UK), investigating gene targeting and lung cancer. He joined the Tianjin Lung Cancer Institute of Tianjin Medical University General Hospital (China) in 2007 as a professor to establish an independent research group, studying the molecular mechanism of metastasis and chemoresistance of lung cancer. He also develops novel chemical compounds to interfere with key cancer promoting pathways. Dr. Ke Xu is an active member of American Association of Cancer Research, American Society for Cell Biology, Chinese Anti-Cancer Association and Chinese Pharmaceutical Association.